Pharmaceuticals
Sanofi fails to win US FDA approval for Genzyme's MS drug Lemtrada
30 Dec 2013
The drug, which gained approval in the EU in September, and in Australia and Canada this month, formed a key part of Sanofi’s $20.1-billion acquisition of Genzyme in 2011
AstraZeneca to acquire Bristol-Myers Squibb’s stake in diabetes business
20 Dec 2013
The acquisition will boost AstraZeneca's presence in the emerging markets, where diabetes is a fast-growing problem and by 2030, is expected to accout of two-thirds of the world's diabetic population
S Korean companies Hanmi and Amneal Pharm launch first copy of AstraZeneca's Nexium in US
20 Dec 2013
Bayer to acquire cancer drug maker Algeta
19 Dec 2013
Bayer and Algeta are partners in the sale of the prostate cancer drug Xofigo, which the US FDA had approved in May
GlaxoSmithKline to stop paying doctors for product promotion
17 Dec 2013
The move comes after the biggest drugmaker in the UK stood accused of making corrupt payments to doctors and officials to boost its drug sales in China
Glaxo announces open offer to hike stake in Indian arm
16 Dec 2013
Betting on rising drug demand, GlaxoSmithKline Plc has earmarked around $1 billion to raise its stake in its Indian subsidiary to 75 per cent
